Amanote Research
Register
Sign In
Cost-Effectiveness and Cost-Utility Analysis of Multiple Treatment Strategies Using Abvd and/or Beacopp in the Treatment of Advanced-Stage Hodgkin Lymphoma
Hematological Oncology
- United Kingdom
doi 10.1002/hon.106_2629
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2019
Authors
A. Prica
A. Vijenthira
K. Chan
M. Cheung
Publisher
Wiley
Related search
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients With Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Cost-Utility Analysis of Cancer Prevention, Treatment, and Control
American Journal of Preventive Medicine
Epidemiology
Public Health
Occupational Health
Environmental
Pcn141 - Cost-Effectiveness Analysis of Obinutuzumab for the Treatment of Patients With Previously Untreated Advanced Follicular Lymphoma in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Utility and Cost-Effectiveness of Internet-Based Treatment for Adults With Depressive Symptoms: Randomized Trial
Journal of Medical Internet Research
Health Informatics
PET-guided Treatment in Advanced-Stage Hodgkin Lymphoma: Yes but Which One?
Oncotarget
Oncology
Cost-Effectiveness Analysis of Lurasidone and Olanzapine in the Treatment of Schizophrenia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Cost-Utility Analysis of Amisulpride and Paliperidone in the Treatment of Schizophrenia
Heliyon
Multidisciplinary
Cost and Cost-Effectiveness of Obesity Treatment: A Mini Review
Health and Primary Care
Advanced Hodgkin Lymphoma in the East of England Cancer Network: A 10-Year Comparative Analysis of Outcomes for ABVD and Escalated-Beacopp Treated Patients Aged 16 to 59
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
